Archive for the ‘Patent Prosecution’ Category

The Fable of the Supreme Court and the Beanstalk

Thursday, May 30th, 2013

Once upon a time, a farmer purchased a magic bean.  The farmer planted his magic bean, as farmers do.  The magic bean grew into a magic beanstalk and made more magic beans.  The farmer harvested the magic beans, as farmers do, and saved the new magic beans for the next year.   For eight years, the farmer planted his new magic beans, grew new magic beanstalks and harvested magic beans for re-planting.

Monsanto, which owned a patent on the magic bean, filed suit against the farmer.  Monsanto believed that the farmer infringed Monsanto’s patent because the farmer made copies of the magic beans, violating the prohibition on making or using a patented product.  Monsanto’s beans were magic because they were genetically modified to survive treatment with glyphosate herbicides.  Use of the genetically modified bean allowed the farmer to kill the weeds in the farmer’s fields using herbicides without damaging his crop.

The farmer believed that once Monsanto sold the magic bean, then Monsanto had no further rights to the bean. The farmer’s friends agreed.  The farmer argued the doctrine of ‘patent exhaustion,’  which means that once a patent owner sells a patented product, the purchaser and any subsequent purchasers can use or sell the product and the patent owner has no further rights to control the patented product.  In this case, the genetically modified soybeans were twice-removed from Monsanto – Monsanto sold the patented soybeans to farmers, the farmers planted the beans, raised crops and sold their crops to a grain elevator, and the grain elevator sold soybeans from the crops to Vernon Bowman, the farmer of our fable.

The case of the magic bean went all the way to the Supreme Court.  On May 13, 2013 a unanimous Court ruled in favor of Monsanto.   The Court concluded that the doctrine of ‘patent exhaustion’ applies only to a particular patented article sold, in this case each genetically-modified soybean sold by Monsanto.  The doctrine allows the farmer to plant or eat soybeans purchased from Monsanto, to grow a crop and to sell the crop.  For soybeans that had the genetic trait and that Mr. Bowman purchased from the grain elevator, Mr. Bowman could re-sell those soybeans, feed the soybeans to animals or eat the soybeans.   However, ‘patent exhaustion’ did not allow Mr. Bowman to make copies of the patented soybeans.  Otherwise, a patent for a seed could never be of any value.  The patent owner could sell the first seed, which would then be copied by infringers, using the self-replicating nature of the seed.  The Court expressly limited the ruling to the facts of the case, recognizing that other situations may arise with other self-replicating inventions, such as computer programs, that might require a different result.

The facts were favorable to Monsanto – Mr. Bowman acted to isolate and duplicate the patented Roundup Ready® soybeans and to take advantage of the herbicide-resistant genetic trait.  He treated his fields with glyphosate herbicide, ensuring that only soybean plants with the Monsanto-owned trait survived.  He also was familiar with the Roundup Ready® beans and used Monsanto-supplied beans for some of his needs.

The Monsanto patents address DNA having specific characteristics and seed and plants containing that DNA.  The Monsanto genetic modification now has been part of the environment for years and eventually will find its way as a contaminant into many, if not all, soybean crops.  The Court was silent on an issue raised in friend-of-the-court briefs; namely, what happens when an organic farmer who does not use herbicides saves seed contaminated with the Monsanto genetic modification.  Isn’t the organic farmer infringing Monsanto’s patent?  In a related question, how can any farmer ever grow any soybeans without being forced to buy Monsanto’s seed due to unintentional genetic contamination?  Those questions currently are in the courts in Organic Seed Growers & Trade Association v Monsanto.

To Be, or Not To Be..

Thursday, May 30th, 2013

Patent Illustration

Pardon the quote of the Bard, but there is one area of patent law that, indeed, ponders “that is the question.” Bear with us for a moment while we try to set the stage. To qualify for a patent, the patent law statute passed by Congress states that an invention must meet three criteria: it must be new, useful, and non-obvious. For our present purposes, we will set aside the useful and non-obvious qualifications. To be new, in essence an invention must not have been thought of (or at least, disclosed) by anyone else. Simple enough.

But the U.S. Supreme Court, as judge made law, has grafted onto patent law the concepts that one cannot obtain a patent on a law of nature, a natural phenomenon, or an abstract idea. For instance, Einstein’s famous equation E=MC2 is said to represent a law of nature and, therefore, be unpatentable. Devices utilizing the law, like the bomb, are patentable. The idea here is that laws of nature belong to everybody and cannot be the exclusive property of anyone, while new applications of the law are patentable. In concept, a pretty straight forward approach. However, recently in the biotechnology realm, the concept of a law of nature has become twisted, contorted, stretched, strained, and abused – but we’ll talk about that another time.

For today, we weill briefly delve into what is meant by “abstract” although we confess up front, that we cannot give you an unambiguous explanation. The meaning of “abstract” lies hidden under the murky waters of patent law involving much judicial semantic nonsense promulgated in major part by the U.S. Supreme Court. One interpretation is that a basic idea of an invention is abstract if it totally captures all possible uses of an idea. In this guise, patent examiners routinely reject applications that seem to have a mathematical expression at their core, especially computer and software implemented inventions. One court has recently expanded the  concept of what may be abstract to the analysis of a method for hedging risk in financial dealings between two parties. Lest you think that we are ducking a good explanation of abstract, another federal appellate court recently decided (CLS Bank Int’l v. Alice Corp.) such a hedging idea was abstract, but could not articulate a consistent interpretation of why. In fact, seven different opinions were filed including at least three different tests for evaluating patent eligibility. Like pornography, the courts seem to know “abstract” when they see it.

 

Which brings us full circle: To be (abstract) or not to be (abstract), that is the question.

To Disclose or Not to Disclose … That is the Question

Tuesday, April 30th, 2013

You have conceived of a wonderful new invention and you want tell everyone, but you are not ready for the expense of a patent application.  Should you open your mouth?

Every inventor feels the tension between the need to maintain secrecy and the need to  disclose the invention.  If you are a regular reader of this newsletter, then you are aware that your sale or offer of sale, public use, or written or verbal disclosure in public can terminate your patent rights forever, with some actions such as public use or sale terminating your rights immediately.  But to develop your invention, you cannot avoid having to disclose.  You have to present written proposals. You have to demonstrate the invention.   You have to consult with others – designers, engineers, manufacturers, business consultants, lawyers, investors and lenders.  How do you talk to other people about your invention, including demonstrating your invention, without losing your patent rights?

You have two options: (a) bite the bullet and file a patent application, or (b) have the persons with whom you are consulting sign non-disclosure agreements.  A non-disclosure agreement is a written contract between you and the person to whom you disclose the invention.  In return for receiving information about your invention, the other person agrees to keep the information in confidence.  After signing, the other person is no longer a member of the public and owes you a duty of secrecy.  If you demonstrate the invention to that person, you are not using the invention ‘in public’ and do not immediately lose your patent rights.  If you disclose the invention to that person in writing, then your written description is not a ‘publication’ and so does not trigger the patent right termination deadlines.  If you describe the invention verbally to that person, then your verbal description does not make the invention ‘otherwise available to the public’ to trigger the running of the time to terminate your patent rights.

The other major advantage of a non-disclosure agreement is that it is immediately enforceable.  If the person who signed the non-disclosure agreement copies your product, you can file suit in court immediately. You do not have to wait the three years or so that it will take for your patent to issue.

There are weaknesses to non-disclosure agreements.  Beware selling or offering the invention for sale. Even if a person signs a non-disclosure agreement, offering to sell the invention to that person likely will terminate your U.S. patent rights instantly and forever.

There is also the problem of who signs the non-disclosure agreement.  If the other person is a corporation, the person signing the non-disclosure agreement on behalf of the corporation must have authority to sign, or at least ‘apparent authority.’  The company CEO has ‘apparent authority.’  The CEO’s secretary does not have ‘apparent authority.’  Without actual or apparent authority on the part of the person signing, the nondisclosure agreement will not protect you.  Demonstration of the invention likely will immediately terminate your patent rights.

There is also the problem of proving that your non-disclosure agreement applies to a particular disclosure.  If, for example, one of the corporation’s employees violates company policy and posts on his Facebook page: “I saw the coolest invention today” along with video of your invention, then it will very difficult to show that a similar invention in, say, a video from Kazakhstan was derived from your disclosure.  That Kazakh video likely will be prior art for your subsequent patent application and may prevent you from obtaining a patent.

Bottom line:  The safest approach is to file a patent application prior to disclosing the invention and certainly prior to demonstrating the invention or selling the product, coupled with non-disclosure agreements with the persons to whom you disclose.  You then have the best of both worlds – you avoid loss of patent rights because your patent application is already filed and you enjoy the ability to immediately enforce the non-disclosure agreement without waiting for that patent to issue.  We can help you with both your patent application and the non-disclosure agreements.

– Robert Yarbrough, Esq.

The Statutory Invention Registration (SIR) is No More

Tuesday, April 30th, 2013

USPTO Seal As of March 16, 2013 the PTO stopped accepting or reviewing applications for SIRs.  Before March 16, the SIR was a technique to notify the world of an invention that the invention owner did not wish to patent.  The effect of the SIR was to dedicate the invention to the public so that anyone could make, use and sell the invention and no one could file a new patent application for it.   SIRs became largely redundant when the U.S. moved to the system of publishing utility patent applications eighteen months after filing.

– Robert Yarbrough, Esq.

The Rush to Meet the March 16th Patent Deadline

Thursday, March 28th, 2013

USPTO Seal According to a chart released by the U.S. PTO, about 26,500 provisional and non-provisional patent applications were filed on March 15, up from the about 2,500 applications that are filed on a typical day.  The reason: inventors and their patent lawyers (including us) were racing to beat the March 16 deadline.

As we have said before in these newsletters, U.S. patent law changed on March 16.  Now, after March 16, patent rights are terminated and lost forever if (a) no patent application has been filed, and (b) there has been a sale or offer for sale of the invention, a public use of the invention, description of the invention in a printed publication, or the invention is ‘otherwise available to the public.’  If you have an invention and intend to take any of these actions, please contact us first so that you do not inadvertently lose your U.S. patent rights.

– Robert Yarbrough, Esq.

PAY ATTENTION: Crucial Deadline for Inventors Is Looming!!

Thursday, February 28th, 2013

USPTO Seal We’ve said it before, but there is an absolutely crucial patent deadline coming up on March 17, 2013 due to a change in U.S. patent law.  Contact us immediately to avoid complete and permanent loss of your patent rights if (a) you have an invention for which you have not yet filed a patent application, and (b), you performed any of the following actions within the last year:

1. You used the invention in public.  That means that you used the invention where someone who does not owe you a duty of secrecy could see you use it.

2. You sold or offered to sell the invention to anyone.

3. The invention was ‘otherwise available’ to the public.

Do any of these situations apply to you?  Contact us immediately.  There still is time to protect your invention before March 17.

Even if the above situations do not apply to you, how do you protect your inventions on or after March 17, 2013?  To avoid instant and complete loss of your patent rights, do not disclose your invention or use your invention where it can be seen by anyone unless that person has signed a non-disclosure agreement or otherwise owes you a duty of secrecy.  Also, do not sell or offer your invention for sale unless you have first filed a patent application.

These laws are new, so no one knows exactly how they will be interpreted; however, there are common situations that we can anticipate now to avoid tragedy later.

Employees: If you have employees, do you have employment agreements with those employees?  Do those employment agreements specify that the employee has the duty to keep company information secret, including information relating to inventions by the employee or by other employees?

Contractors:  Do you utilize private contractors, such as engineers, designers, plumbers and the cleaning crew?  Do your contracts specify that the contractor and employees of the contractor have the duty to keep company inventions secret?

Visitors:  Do visitors come to your facility?  If a visitor, say, walks into a room at your plant where a new invention is in operation, operation of the invention could be considered use of the invention in public or could be considered making the invention ‘otherwise available’ to the public, instantly terminating your patent rights.   You can avoid this result by having visitors sign non-disclosure agreements for the privilege of entering your building.  As a less-intrusive option, incorporate a non-disclosure paragraph into a sign-in sheet and require that all visitors and contractors sign the sheet.

Customers:  As noted, do not sell or offer your invention for sale until the patent application is filed.  A sale or offer of sale will immediately terminate patent rights even if the customer signed an agreement to keep the invention secret.

The patent world changes on March 17, 2013.  Please protect yourself so that you do not lose your patent rights.

– Robert Yarbrough, Esq.

PTO Patent Fees for the ‘Micro Entity’

Thursday, January 31st, 2013

microscope

As an individual or small business inventor, do you feel really, really small?  The good news: after March 16, 2013 you may qualify as a ‘micro entity’ and be entitled to patent fee discounts from the PTO of 75% off large entity rates.  The bad news: large and small entity rates are going up at the PTO.

An application is subject to reduced ‘micro entity‘ fees if all of the inventors or inventions owners can certify to the following:

1. The applicant or inventor is a ‘small entity;’ that is, the applicant generally has fewer than 500 employees.

2. The applicant or inventor is named as an inventor on no more than four prior utility patent applications, not counting provisional applications, applications in foreign countries, or applications assigned to a previous employer.

3. Neither the applicant nor a person to whom the applicant had a duty to assign the invention had a gross income of not more than three times the median household income for the year prior to the filing date and the applicant is not obligated to assign the invention to a person with an income greater than that amount.  The PTO cites 2011 U.S. Census Bureau statistics for a median household income of $50,054.00. The maximum gross income of the ‘micro entity’ applicant therefore cannot exceed $150,162.00.  The gross income ceiling effectively limits  micro entity status to individual inventors.

A false micro entity certification is fraud on the patent office and will invalidate any resulting patent and likely lead to sanctions against any patent attorneys or agents involved.  An honest mistake can be rectified upon submission of appropriate certifications and payment of the fees owed.

Colleges and universities automatically qualify as ‘micro entities’ without meeting the above criteria.  An employee of a college or university also qualifies without meeting the above qualifications.

Qualifying as a ‘micro entity’ will be valuable.   After March 16, 2013.  The filing fees to file a new utility patent application with the PTO for a large entity will be $1,600.00.  A ‘small entity’ (fewer than 500 employees) will pay $800.00.  A ‘micro entity’ will pay $400.00. The PTO estimates that 31% of applications will be filed by ‘micro entities.’

–Robert Yarbrough, Esq.

Unified European Patent

Monday, December 31st, 2012

Europe

If you want to protect a product by patent in Europe today, you generally will file an application in the European Patent Office (“EPO”).  When your application is (eventually) reviewed and approved by the EPO, you then must register the approved application with each individual European country in which you desire a patent and must file any translations required by the individual country.   The actual patents are issued by the individual countries and are enforced in the courts of the individual countries.  You must pay ‘annuities’ every year to each individual country to maintain the patent in effect in that country.   The process is time consuming, duplicative, and expensive.

All of that is about to change.  The European Parliament has passed a regulation to create a ‘Unified Patent’ to be issued by the EPO and enforced by centralized European courts.  The Unified Patent will bypass the registration process in individual countries, avoid translation expenses, avoid local annuities, and avoid the need to file multiple lawsuits in multiple countries to either enforce or attack a patent.  To take effect, the new system must be ratified by thirteen European Union member states including France, Germany and the UK.

Italy and Spain are not in agreement with the Unitary Patent regulation and likely will not participate.

– Robert Yarbrough, Esq.

Beware the Ides of March (well, almost the Ides)

Friday, November 30th, 2012

caesar We’ve said it before, but it bears repeating.  Remember that on or after March 17, 2013, you MUST protect your invention before offering the invention for sale or using the invention in public.  Otherwise, you lose your U.S. patent rights instantly and forever.  This is a major change in the law and requires an entirely new level of paranoia on the part of inventors and the companies that employ them.  How can you protect yourself and your company?

On or after March 17, 2013:

(1) Do not offer the invention or a product including the invention for sale until you file a patent application.

(2) Do not use the invention in public until you file a patent application.

(3) Do not disclose the invention to someone else unless you have filed a patent application or unless that person has signed a non-disclosure agreement.  Disclosure of the invention by you does not immediately terminate your U.S. patent rights, but does immediately terminate foreign patent rights in most circumstances.

PLEASE keep that above in mind and do not forfeit your rights by mistake.  For more information, follow this link.

– Robert Yarbrough

My Competitor is Telling the PTO to Deny My Patent Application! What Can I do?

Friday, September 28th, 2012

heavy workload

Thanks to the America Invents Act, you’ll have to live with it, if your competitor submits the information on time and meets other requirements.  As of September 16, 2012, persons who are not the patent applicant can file papers and make arguments to the patent examiner as to why someone else’s patent application should be denied.

The hope is that the participation of third parties in the patent process will result in better quality prior art coming to the attention of examiners and ultimately better quality patents.

Why would third party argument and prior art make the system better?

One of the dirty little secrets of the Patent and Trademark Office (“PTO”) is that its examiners are given relatively little time to examine patent applications.  Typically, the PTO allows an examiner between 14 to 30 hours (with an average of 22 hours) to examine each patent application depending on the complexity of the technology and the skill level of the examiner. In those few hours, the examiner must read the application, search for any prior art relevant to the invention, analyze the patentability of the invention, prepare a response to the applicant, and, finally, dispose of the application. Examiners and are under constant pressure to produce and are under constant review to ensure that they meet their production quotas.

Patent quality is hampered not only by a lack of time but also by the adequacy (or lack thereof) of the prior art databases available to the examiners. Especially in art areas where there is significant inventive activity (electronics and software for example), the ability to keep up with and search all publications becomes a daunting task. As a consequence, some poor-quality patents are issued for non-inventions.

To encourage interested persons to locate and report prior art to the patent examiners, the PTO has endorsed a website known as Ask Patents where persons concerned about a patent application can tap into crowd sourcing for prior art. Here is an example of an Ask Patents discussion. The public will be able to use patent resources (such as Google Patent Search) to find applications in which they are interested and to submit what they believe to be prior art relevant to that patent. The site will allow participants to vote on the relative merits of the prior art, and the ten best citations will be forwarded to the PTO.

So what do you do if you are worried about an attack by your competitor on your patent application?

For your competitor to present prior art and make arguments to the PTO, the competitor must first know about your patent application.  Your competitor usually will learn about your application in either of two ways (1) you notify your competitor or (2) your patent application is published by the PTO and your competitor finds the publication.  Patent applications are published 18 months after the first application is filed, unless the applicant specifically requests that the application NOT be published.  The only reason to allow publication is if you intend to seek protection in other countries.  If you will not seek foreign patent protection, then the risk of third party argument and prior art is a good reason to ask that your patent application NOT be published.

– Robert Yarbrough, Esq. and Laurence Weinberger, Esq.